TITLE

Companies tighten their belts

PUB. DATE
October 2007
SOURCE
Pharmaceutical Representative;Oct2007, Vol. 37 Issue 10, p10
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers news briefs related to pharmaceutical industries. New Brunswick, New Jersey-based Johnson & Johnson has announced plans to trim $1.3 billion to $1.6 billion from its 2008 pre-tax expenses. California-based Amgen Inc. is cutting 12% to 14% of its staff, although the company indicated that none of the headcount reductions will occur within the sales function. AstraZeneca PLC has expanded its previously announced restructuring plan.
ACCESSION #
26947393

 

Related Articles

  • J&J pharma division to be split three ways, each with R&D. McGuire, Stephen // Medical Marketing & Media;Jun2006, Vol. 41 Issue 6, p12 

    The article reports on the reorganization made by the Johnson & Johnson of its pharmaceuticals business in the U.S. The reorganization divides the business into three major therapeutic clusters, each with its own research and development function. David Norton, Kris Peterson, and Julie McHugh...

  • Pharma Majors Plan Job Cuts. Scott, Alex // Chemical Week;8/15/2007, Vol. 169 Issue 27, p25 

    The article deals with the job-cut plans of major companies in the pharmaceutical industry as part of their ongoing restructuring programs in 2007. These companies include AstraZeneca, Bristol-Myers Squibb and Johnson and Johnson (J&J). The companies cite the need to significantly cut costs....

  • Amgen: Winner takes all.  // Medical Marketing & Media;Feb99, Vol. 34 Issue 2, p24 

    Reports on the ruling of an arbitration panel granting Amgen Inc. the rights for a drug used in treating anemia. Amgen's dispute with Johnson & Johnson Co. over the drug.

  • Amgen wins NESP arbitration in Johnson & Johnson conflict. Van Arnum, Patricia // Chemical Market Reporter;12/28/98, Vol. 254 Issue 26, p5 

    Reports that Amgen Inc. has won arbitration in its dispute with Johnson & Johnson Co. over rights to its red blood stimulating product candidate. Amgen's licensing agreement with Johnson & Johnson; Amgen's rights to develop and market the product as a result of the decision.

  • Pharmaceuticals Industry Profile: United States.  // Pharmaceuticals Industry Profile: United States;Dec2005, p1 

    Presents a profile of the Pharmaceuticals industry in the United States. Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the industry; Market forecasts; Demographics; Further reading.

  • FDA TURNS UP HEAT ON PHARMACEUTICAL MARKETERS. Dickinson, James G. // Medical Marketing & Media;Apr2001, Vol. 36 Issue 4, p38 

    Reports developments on pharmaceutical marketers issues in the U.S. as of April 2001. Development of direct-to-consumer print and television campaign by GlaxoSmithKline PLC; Creation of the consumer Web site for Zomig tablets by AstraZeneca PLC; Opposition of Johnson & on the regulations...

  • Weekly Stock Performance (as of April 12, 2013).  // MondayMorning;4/15/2013, Vol. 21 Issue 14, p1 

    A table is presented which lists the weekly stock performance for several pharmaceutical companies of the U.S. including AstraZeneca PLC, GlaxoSmithKline, and Johnson and Johnson.

  • Pharma Deals Help Illumina Pad Its Gene-Sequencing Lead. VANCE CARIAGA // Investors Business Daily;10/9/2014, pA05 

    When you become the 800-pound gorilla in your industry, you don't suddenly decide that 800 pounds is enough. Instead, you start looking for ways to reach 900 pounds, or 1,000, or some weight that breaks the scales altogether.

  • CNS News Round-Up.  // PharmaWatch: CNS;Jun2006, Vol. 5 Issue 6, p2 

    The article reports on developments in the pharmaceutical industry as of June 2006. Abraxis BioScience has acquired the anesthetic and analgesics portfolio of AstraZeneca. Johnson & Johnson has requested for marketing approval for its paliperidone prolonged release tablets for the treatment of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics